Filing metadata

Accession number
0001683168-19-003514
Form type
Form 3
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
Nov 08, 2019
Reporting period
Nov 07, 2019
Description
Initial ownership

Explore SEC Filings Hub